Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review

…, M Aghakouchakzadeh, E Kordzadeh-Kermani… - Journal of the American …, 2021 - jacc.org
Endothelial injury and microvascular/macrovascular thrombosis are common
pathophysiological features of coronavirus disease-2019 (COVID-19). However, the optimal …

Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19)

E Kordzadeh-Kermani, H Khalili… - Future microbiology, 2020 - Future Medicine
Aim: Despite the similarities in the pathogenesis of the beta coronaviruses, the precise infective
mechanisms of SARS-CoV-2 remain unclear. Objective: In this review, we aim to focus …

[HTML][HTML] Anti-Leishmania activity of osthole

EK Kermani, SE Sajjadi, SH Hejazi… - Pharmacognosy …, 2016 - ncbi.nlm.nih.gov
Background: Treatment of cutaneous leishmaniasis (CL) is occasionally highly resistant to
pentavalent antimonials, the gold standard in pharmacotherapy of CL. Since there is no …

Antithrombotic therapy in COVID-19: systematic summary of ongoing or completed randomized trials

…, M Aghakouchakzadeh, E Kordzadeh-Kermani… - medRxiv, 2021 - medrxiv.org
Endothelial injury and microvascular/macrovascular thrombosis are common
pathophysiologic features of coronavirus disease-2019 (COVID-19). However, the optimal …

Prevention strategies to minimize the infection risk associated with biologic and targeted immunomodulators

E Kordzadeh-Kermani, H Khalili… - Infection and Drug …, 2020 - Taylor & Francis
The introduction of biologic and targeted immunomodulators is a significant breakthrough in
the therapeutic area of various fields of medicine. The occurrence of serious infections, a …

Antithrombotic Therapy in COVID-19: Systematic Summary of Ongoing or Completed Randomized Trials (preprint)

…, BW Van Tassell, E Kordzadeh-Kermani… - 2021 - pesquisa.bvsalud.org
Endothelial injury and microvascular/macrovascular thrombosis are common
pathophysiologic features of coronavirus disease-2019 (COVID-19). However, the optimal …

Drug-based therapeutic strategies for COVID-19-infected patients and their challenges

K Zarkesh, E Entezar-Almahdi, P Ghasemiyeh… - Future …, 2021 - Future Medicine
Emerging epidemic-prone diseases have introduced numerous health and economic
challenges in recent years. Given current knowledge of COVID-19, herd immunity through …

Atorvastatin versus Placebo in Patients with COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION-S Randomised Controlled Trial

A Talasaz, TH Center, B Sharif-Kashani, S Rezaian… - 2021 - bmj.com
Objectives: To assess the effect of statin therapy versus placebo on clinical outcomes of
patients with COVID-19 admitted to the intensive care unit (ICU). Design: INSPIRATION/…

[HTML][HTML] Коронавирусная инфекция при ожирении

СН Ионов, СС Саидов, ОВ Абанина… - … , врач и здоровье, 2021 - cyberleninka.ru
Актуальность темы: большая часть земного шара страдает ожирением и имеется
достаточно случаев воздействия данной патологии на развитие осложненного и тяжелого …

[PDF][PDF] Intracranial Hypotension After Severe Covid-19. Case Report and

H Foyaca-Sibat, LFI Valdés - scholar.archive.org
Background: Despite the lack of clinical research done, new mutations of COVID-19 are
travelling all over the world, and sooner or later, unexpected consequences going to be seen. In …